Edwards Lifesciences Corp - Common Stock (EW)

CUSIP: 28176E108

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 7 signals
Share change
-6,087,902
Put/Call ratio
70%
SEC-reported price per share
$72.48
Indexed holders
1,190
Value change
-$465,368,232
Number of buys
483
Open additional details 1 more signal available
Number of sells
607
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
576,625,106

Security key

28176E108

Report period

Q1 2025

Indexed institutions

1,190

Top holders

10

Ownership snapshot

Top reported holders of EW - Edwards Lifesciences Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
31 Dec 2024
13F Highest disclosed value: $5,117,844,625 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $5.12B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value Top 5
VANGUARD GROUP INC $5.12B
BlackRock, Inc. $4.04B
WELLINGTON MANAGEMENT GROUP LLP $2.46B
STATE STREET CORP $1.91B
Bank of New York Mellon Corp $1.34B

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$5,117,844,625
69,132,036 shares
— 31 Dec 2024
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$4,036,139,291
54,520,320 shares
— 31 Dec 2024
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$2,458,601,372
33,210,879 shares
— 31 Dec 2024
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$1,910,629,257
25,808,622 shares
— 31 Dec 2024
Bank of New York Mellon Corp
13F
Company
13F
—
denominator unverified
$1,341,802,736
18,125,121 shares
— 31 Dec 2024
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$1,099,480,834
14,851,827 shares
— 31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
1,190
Shares
498,551,233
Indexed holders
1,190
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 indexed holders
1,216
Q1 2025 indexed holders
1,190
Indexed holder difference
-26
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 value Q1 2025 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .